Clinical Trial

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PN-881 in healthy adult participants.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-06
notable Primary completion pushed: 2026-06-15 -> 2026-07-29 2026-08-06
minor Completion pushed: 2026-06-15 -> 2026-07-29 2026-08-06
Trial Details
NCT Number NCT07153146
Lead Sponsor Protagonist Therapeutics, Inc.
Conditions Healthy Volunteer
Enrollment 146 participants
Start Date 2025-10-07
Primary Completion 2026-07-29 (estimated)
Study Completion 2026-07-29 (estimated)
Updated on ClinicalTrials.gov 2026-08-05